trifluoperazine + trihexyphenidyl hydrochloride Tablets 2.5 mg+1 mg, 5 mg+2 mg, 10 mg+2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19372
This pharmaceutical company specializes in a wide range of prescription medications and over-the-counter drugs targeting several key therapy areas. Their primary focus lies in psychotropic and central nervous system (CNS) products, including antidepressants, antipsychotics, and anticonvulsants. They also offer cardiovascular and diabetes medications, as well as general healthcare products like vitamins and antacids. The company manufactures its products in various dosage forms, such as tablets, capsules, syrups, and injectables. They hold WHO-GMP certifications, demonstrating their commitment to quality and regulatory compliance. Their product portfolio includes patented formulations and they are actively expanding their operations within the EU and North America.

Manufacturer usually replies in 26 days

None